Smaller gene-editing system could expand treatment options for cancer, ALS and other diseases.

NIH-supported clinical trial shows coordinated care strategy more effective than standard care

Positive safety profile of novel drug compound is surprise for class of synthetic opioids shelved years ago.

Competition sought bold ideas to better understand how dietary interventions could influence disease onset and symptom management.